> top > docs > PMC:7502678 > annotations

PMC:7502678 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 4147-4155 Body_part denotes Appendix http://purl.org/sig/ont/fma/fma14542
T2 5587-5609 Body_part denotes central nervous system http://purl.org/sig/ont/fma/fma55675
T3 5611-5614 Body_part denotes CNS http://purl.org/sig/ont/fma/fma55675
T4 9420-9431 Body_part denotes vagus nerve http://purl.org/sig/ont/fma/fma5731
T5 12716-12722 Body_part denotes mental http://purl.org/sig/ont/fma/fma264279
T6 12751-12765 Body_part denotes cranial nerves http://purl.org/sig/ont/fma/fma63820
T7 15496-15499 Body_part denotes CNS http://purl.org/sig/ont/fma/fma55675
T8 16640-16645 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T9 16678-16692 Body_part denotes nervous system http://purl.org/sig/ont/fma/fma7157
T10 22788-22794 Body_part denotes mental http://purl.org/sig/ont/fma/fma264279
T11 23024-23029 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 5587-5609 Body_part denotes central nervous system http://purl.obolibrary.org/obo/UBERON_0001017
T2 5595-5609 Body_part denotes nervous system http://purl.obolibrary.org/obo/UBERON_0001016
T3 5611-5614 Body_part denotes CNS http://purl.obolibrary.org/obo/UBERON_0001017
T4 9420-9431 Body_part denotes vagus nerve http://purl.obolibrary.org/obo/UBERON_0001759
T5 9426-9431 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T6 12751-12765 Body_part denotes cranial nerves http://purl.obolibrary.org/obo/UBERON_0001785
T7 15496-15499 Body_part denotes CNS http://purl.obolibrary.org/obo/UBERON_0001017
T8 16640-16645 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T9 16678-16692 Body_part denotes nervous system http://purl.obolibrary.org/obo/UBERON_0001016
T10 23024-23029 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 14-22 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 26-34 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T3 66-74 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T4 108-116 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 175-183 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T6 376-384 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T7 746-754 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T8 894-902 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 1519-1543 Disease denotes virus infectious disease http://purl.obolibrary.org/obo/MONDO_0005108
T10 1525-1543 Disease denotes infectious disease http://purl.obolibrary.org/obo/MONDO_0005550
T11 1550-1558 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 1634-1642 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T13 1721-1729 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T14 1779-1787 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T15 1898-1906 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T16 2013-2021 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T17 2129-2137 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T18 2250-2258 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T19 4777-4785 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T20 5023-5031 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T21 5159-5167 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T22 5228-5236 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T23 5282-5290 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T24 5390-5398 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T25 5620-5626 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T26 5632-5640 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T27 5680-5694 Disease denotes cardiac arrest http://purl.obolibrary.org/obo/MONDO_0000745
T28 5698-5704 Disease denotes stroke http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T30 6100-6108 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T31 6272-6280 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T32 6320-6328 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T33 6981-6989 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T34 7008-7016 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T35 7110-7118 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T36 8075-8098 Disease denotes anxiety, and depression http://purl.obolibrary.org/obo/MONDO_0041086
T37 8075-8082 Disease denotes anxiety http://purl.obolibrary.org/obo/MONDO_0005618|http://purl.obolibrary.org/obo/MONDO_0011918
T39 8088-8098 Disease denotes depression http://purl.obolibrary.org/obo/MONDO_0002050
T40 8156-8164 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T41 8375-8383 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T42 9157-9160 Disease denotes CMS http://purl.obolibrary.org/obo/MONDO_0018940
T43 9386-9394 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T44 9671-9679 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T45 10060-10068 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T46 10102-10111 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T47 10562-10570 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T48 10625-10633 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T49 10768-10771 Disease denotes ASM http://purl.obolibrary.org/obo/MONDO_0020333
T50 10803-10811 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T51 11459-11467 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T52 12635-12643 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T53 12767-12776 Disease denotes nystagmus http://purl.obolibrary.org/obo/MONDO_0005712
T54 12782-12788 Disease denotes ataxia http://purl.obolibrary.org/obo/MONDO_0000437
T55 12994-13002 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T56 13613-13621 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T57 13892-13900 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T58 14197-14206 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T59 14285-14293 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T60 14333-14336 Disease denotes CMS http://purl.obolibrary.org/obo/MONDO_0018940
T61 14694-14702 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T62 15277-15285 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T63 15319-15340 Disease denotes respiratory infection http://purl.obolibrary.org/obo/MONDO_0024355
T64 15331-15340 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T65 15363-15371 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T66 15684-15702 Disease denotes status epilepticus http://purl.obolibrary.org/obo/MONDO_0002125
T67 15704-15706 Disease denotes SE http://purl.obolibrary.org/obo/MONDO_0002125
T68 15814-15822 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T69 15872-15874 Disease denotes SE http://purl.obolibrary.org/obo/MONDO_0002125
T70 15985-16006 Disease denotes acute stress reaction http://purl.obolibrary.org/obo/MONDO_0005457
T71 16011-16023 Disease denotes hypocalcemia http://purl.obolibrary.org/obo/MONDO_0018543
T72 16122-16130 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T73 16205-16213 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T74 16434-16442 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T75 16512-16520 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T76 16570-16586 Disease denotes systemic disease http://purl.obolibrary.org/obo/MONDO_0015938
T77 16634-16653 Disease denotes multi-organ failure http://purl.obolibrary.org/obo/MONDO_0043726
T78 16694-16704 Disease denotes meningitis http://purl.obolibrary.org/obo/MONDO_0004796|http://purl.obolibrary.org/obo/MONDO_0021108
T80 16705-16717 Disease denotes encephalitis http://purl.obolibrary.org/obo/MONDO_0019956
T81 16914-16933 Disease denotes Meningoencephalitis http://purl.obolibrary.org/obo/MONDO_0005845
T82 16950-16958 Disease denotes COVID 19 http://purl.obolibrary.org/obo/MONDO_0100096
T83 17209-17217 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T84 17276-17278 Disease denotes SE http://purl.obolibrary.org/obo/MONDO_0002125
T85 17355-17363 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T86 17405-17413 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T87 17510-17518 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T88 17527-17546 Disease denotes meningoencephalitis http://purl.obolibrary.org/obo/MONDO_0005845
T89 17705-17713 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T90 17862-17870 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T91 18094-18102 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T92 18134-18136 Disease denotes SE http://purl.obolibrary.org/obo/MONDO_0002125
T93 18257-18265 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T94 18353-18361 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T95 18572-18580 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T96 18640-18648 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T97 18772-18780 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T98 18808-18816 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T99 19311-19319 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T100 19724-19733 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T101 19805-19813 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T102 19935-19943 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T103 19966-19974 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T104 20102-20105 Disease denotes ASM http://purl.obolibrary.org/obo/MONDO_0020333
T105 20220-20223 Disease denotes ASM http://purl.obolibrary.org/obo/MONDO_0020333
T106 20645-20653 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T107 20670-20673 Disease denotes ASM http://purl.obolibrary.org/obo/MONDO_0020333
T108 20764-20772 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T109 20780-20788 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T110 20842-20850 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T111 20873-20881 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T112 20886-20894 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T113 21047-21055 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T114 21302-21310 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T115 21368-21374 Disease denotes stroke http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T117 21419-21427 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T118 21497-21505 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T119 21785-21793 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T120 21885-21893 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T121 22154-22162 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T122 23097-23105 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T123 24340-24348 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T124 24417-24425 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T125 24780-24788 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T126 24984-24992 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T127 24993-25002 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T128 25461-25469 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T129 25473-25481 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T130 25513-25521 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T131 25657-25665 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T132 25669-25677 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T133 25709-25717 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T134 25874-25882 Disease denotes Epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T135 26591-26594 Disease denotes MBA http://purl.obolibrary.org/obo/MONDO_0043219

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 41-42 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T2 126-129 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T3 682-683 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T4 1354-1355 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 1380-1381 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 1488-1489 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T7 1519-1524 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T8 1569-1572 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T9 1703-1706 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T10 1818-1819 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T11 2068-2069 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T12 3022-3024 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T13 3052-3053 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T14 3118-3119 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T15 3385-3386 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T16 3642-3643 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T17 3686-3687 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T18 4095-4096 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T19 4220-4221 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T20 5048-5049 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T21 5297-5298 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T22 5346-5347 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T23 5587-5609 http://purl.obolibrary.org/obo/UBERON_0001017 denotes central nervous system
T24 5587-5609 http://www.ebi.ac.uk/efo/EFO_0000302 denotes central nervous system
T25 5587-5609 http://www.ebi.ac.uk/efo/EFO_0000908 denotes central nervous system
T26 5611-5614 http://www.ebi.ac.uk/efo/EFO_0000302 denotes CNS
T27 5611-5614 http://www.ebi.ac.uk/efo/EFO_0000908 denotes CNS
T28 5611-5614 http://purl.obolibrary.org/obo/UBERON_0001017 denotes CNS
T29 6110-6111 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T30 6361-6362 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T31 6444-6445 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T32 6758-6759 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T33 7258-7260 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T34 7464-7471 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T35 8174-8177 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T36 8194-8195 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T37 8451-8452 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T38 8603-8610 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T39 9426-9431 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
T40 9707-9708 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T41 10147-10148 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T42 10158-10160 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T43 11584-11587 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T44 11970-11971 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T45 12759-12765 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T46 12958-12963 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T47 13486-13492 http://purl.obolibrary.org/obo/OBI_0000968 denotes device
T48 13493-13496 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T49 13697-13698 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T50 14154-14156 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T51 14261-14273 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T52 14297-14298 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T53 14708-14709 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T54 15206-15213 http://purl.obolibrary.org/obo/CLO_0009985 denotes focused
T55 15317-15318 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T56 15496-15499 http://www.ebi.ac.uk/efo/EFO_0000302 denotes CNS
T57 15496-15499 http://www.ebi.ac.uk/efo/EFO_0000908 denotes CNS
T58 15496-15499 http://purl.obolibrary.org/obo/UBERON_0001017 denotes CNS
T59 15733-15734 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T60 16138-16139 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T61 16457-16458 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T62 16640-16645 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T63 16724-16725 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T64 16983-16986 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T65 17246-17247 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T66 17282-17283 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T67 17312-17313 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T68 17366-17367 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T69 17475-17478 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T70 17495-17496 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T71 17603-17604 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T72 17961-17962 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T73 18288-18289 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T74 18508-18509 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T75 18627-18628 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T76 19850-19853 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T77 19984-19985 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T78 20106-20109 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T79 20119-20120 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T80 20316-20319 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T81 20717-20720 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T82 20729-20730 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T83 20859-20862 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T84 20871-20872 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T85 20967-20969 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T86 21062-21064 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T87 21149-21150 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T88 21266-21269 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T89 21507-21510 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T90 21642-21645 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T91 21804-21805 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T92 22316-22317 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T93 22509-22511 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T94 22942-22949 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T95 22960-22961 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T96 23116-23123 http://purl.obolibrary.org/obo/CLO_0009985 denotes focused
T97 23220-23223 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T98 23486-23494 http://purl.obolibrary.org/obo/CLO_0001658 denotes actively
T99 23572-23581 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremely
T100 24006-24007 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T101 24435-24438 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T102 24444-24445 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T103 24501-24502 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T104 24972-24973 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T105 25078-25081 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T106 25488-25489 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T107 25684-25685 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T108 25841-25842 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T109 26012-26022 http://purl.obolibrary.org/obo/OBI_0000968 denotes instrument
T110 26041-26043 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T111 26062-26064 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T112 26085-26087 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T113 26105-26107 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T114 26124-26126 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T115 26143-26145 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T116 26171-26173 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T117 26191-26193 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T118 26210-26212 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T119 26341-26351 http://purl.obolibrary.org/obo/CLO_0001658 denotes Activities
T120 26398-26400 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T121 26423-26425 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T122 26444-26446 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T123 26471-26473 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T124 26490-26492 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T125 26507-26509 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T126 26526-26528 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T127 26551-26553 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T128 26587-26589 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T129 27141-27144 http://purl.obolibrary.org/obo/CLO_0050167 denotes LLC
T130 27704-27705 http://purl.obolibrary.org/obo/CLO_0001020 denotes A

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 1512-1518 Chemical denotes corona http://purl.obolibrary.org/obo/CHEBI_37409
T2 3654-3659 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T3 4515-4518 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T4 7483-7486 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T5 7497-7500 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T6 9174-9177 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T7 10287-10290 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T8 10466-10471 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T9 10602-10605 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T10 10977-10990 Chemical denotes levetiracetam http://purl.obolibrary.org/obo/CHEBI_6437
T11 10995-11004 Chemical denotes midazolam http://purl.obolibrary.org/obo/CHEBI_6931
T12 11037-11039 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T13 11040-11055 Chemical denotes benzodiazepines http://purl.obolibrary.org/obo/CHEBI_22720
T14 11357-11359 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T15 13780-13783 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T16 15704-15706 Chemical denotes SE http://purl.obolibrary.org/obo/CHEBI_74813
T17 15872-15874 Chemical denotes SE http://purl.obolibrary.org/obo/CHEBI_74813
T18 17276-17278 Chemical denotes SE http://purl.obolibrary.org/obo/CHEBI_74813
T19 17618-17621 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T20 18134-18136 Chemical denotes SE http://purl.obolibrary.org/obo/CHEBI_74813
T21 18427-18444 Chemical denotes immunosuppressant http://purl.obolibrary.org/obo/CHEBI_35705
T22 18540-18543 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T23 19496-19499 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T24 20259-20272 Chemical denotes levetiracetam http://purl.obolibrary.org/obo/CHEBI_6437
T25 20404-20413 Chemical denotes midazolam http://purl.obolibrary.org/obo/CHEBI_6931
T26 20418-20426 Chemical denotes propofol http://purl.obolibrary.org/obo/CHEBI_44915
T27 26041-26043 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T28 26062-26064 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T29 26085-26087 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T30 26105-26107 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T31 26124-26126 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T32 26143-26145 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T33 26171-26173 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T34 26191-26193 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T35 26210-26212 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T36 26398-26400 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T37 26423-26425 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T38 26444-26446 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T39 26471-26473 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T40 26490-26492 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T41 26507-26509 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T42 26526-26528 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T43 26530-26532 Chemical denotes MA http://purl.obolibrary.org/obo/CHEBI_474859|http://purl.obolibrary.org/obo/CHEBI_73610|http://purl.obolibrary.org/obo/CHEBI_90325
T46 26551-26553 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T47 26587-26589 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T48 26963-26965 Chemical denotes SK http://purl.obolibrary.org/obo/CHEBI_144702

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 14-22 Disease denotes COVID-19 MESH:C000657245
4 26-34 Disease denotes Epilepsy MESH:D004827
5 66-74 Disease denotes Epilepsy MESH:D004827
17 163-169 Species denotes people Tax:9606
18 732-740 Species denotes patients Tax:9606
19 880-888 Species denotes patients Tax:9606
20 108-116 Disease denotes COVID-19 MESH:C000657245
21 175-183 Disease denotes epilepsy MESH:D004827
22 376-384 Disease denotes Epilepsy MESH:D004827
23 746-754 Disease denotes COVID-19 MESH:C000657245
24 793-800 Disease denotes seizure MESH:D012640
25 868-876 Disease denotes seizures MESH:D012640
26 894-902 Disease denotes COVID-19 MESH:C000657245
27 931-939 Disease denotes seizures MESH:D012640
39 1622-1628 Species denotes people Tax:9606
40 1935-1943 Species denotes patients Tax:9606
41 1512-1548 Disease denotes corona virus infectious disease-2019 MESH:C000657245
42 1550-1558 Disease denotes COVID-19 MESH:C000657245
43 1634-1642 Disease denotes epilepsy MESH:D004827
44 1721-1729 Disease denotes epilepsy MESH:D004827
45 1779-1787 Disease denotes Epilepsy MESH:D004827
46 1898-1906 Disease denotes COVID-19 MESH:C000657245
47 2013-2021 Disease denotes Epilepsy MESH:D004827
48 2129-2137 Disease denotes epilepsy MESH:D004827
49 2250-2258 Disease denotes Epilepsy MESH:D004827
51 3327-3334 Species denotes patient Tax:9606
53 3816-3823 Species denotes patient Tax:9606
57 4777-4785 Disease denotes COVID-19 MESH:C000657245
58 5023-5031 Disease denotes COVID-19 MESH:C000657245
59 5159-5167 Disease denotes COVID-19 MESH:C000657245
61 5228-5236 Disease denotes COVID-19 MESH:C000657245
63 5255-5262 Species denotes Patient Tax:9606
66 5269-5277 Disease denotes Seizures MESH:D012640
67 5282-5290 Disease denotes COVID-19 MESH:C000657245
80 5399-5407 Species denotes patients Tax:9606
81 5632-5642 Species denotes SARS-CoV-2 Tax:2697049
82 5378-5386 Disease denotes seizures MESH:D012640
83 5390-5398 Disease denotes COVID-19 MESH:C000657245
84 5468-5476 Disease denotes seizures MESH:D012640
85 5489-5496 Disease denotes seizure MESH:D012640
86 5652-5660 Disease denotes seizures MESH:D012640
87 5680-5694 Disease denotes cardiac arrest MESH:D006323
88 5698-5704 Disease denotes stroke MESH:D020521
89 5798-5806 Disease denotes seizures MESH:D012640
90 5870-5891 Disease denotes tonic–clonic seizures MESH:D004830
91 5922-5930 Disease denotes seizures MESH:D012640
96 6100-6108 Disease denotes COVID-19 MESH:C000657245
97 6151-6158 Disease denotes seizure MESH:D012640
98 6251-6259 Disease denotes seizures MESH:D012640
99 6272-6280 Disease denotes COVID-19 MESH:C000657245
112 6320-6330 Species denotes SARS-CoV-2 Tax:2697049
113 6400-6408 Species denotes patients Tax:9606
114 6677-6689 Species denotes participants Tax:9606
115 6306-6314 Disease denotes infected MESH:D007239
116 6373-6380 Disease denotes seizure MESH:D012640
117 6459-6466 Disease denotes seizure MESH:D012640
118 6533-6540 Disease denotes seizure MESH:D012640
119 6587-6604 Disease denotes sleep deprivation MESH:D012892
120 6746-6754 Disease denotes seizures MESH:D012640
121 6770-6786 Disease denotes emotional stress MESH:D000079225
122 6882-6889 Disease denotes seizure MESH:D012640
123 6923-6928 Disease denotes sleep MESH:D012893
125 6981-6989 Disease denotes COVID-19 MESH:C000657245
127 7008-7016 Disease denotes Epilepsy MESH:D004827
129 7110-7118 Disease denotes COVID-19 MESH:C000657245
136 7924-7932 Species denotes patients Tax:9606
137 8235-8243 Species denotes patients Tax:9606
138 7945-7955 Disease denotes epilepsies MESH:D004827
139 8075-8082 Disease denotes anxiety MESH:D001007
140 8088-8098 Disease denotes depression MESH:D000275
141 8156-8164 Disease denotes COVID-19 MESH:C000657245
143 8375-8383 Disease denotes COVID-19 MESH:C000657245
145 9028-9035 Species denotes patient Tax:9606
151 9413-9417 Species denotes EMUs Tax:8790
152 9344-9349 Disease denotes COVID MESH:C000657245
153 9386-9394 Disease denotes epilepsy MESH:D004827
154 9601-9606 Disease denotes COVID MESH:C000657245
155 9671-9679 Disease denotes COVID-19 MESH:C000657245
161 10021-10029 Species denotes patients Tax:9606
162 10363-10367 Species denotes EMUs Tax:8790
163 10060-10068 Disease denotes COVID-19 MESH:C000657245
164 10102-10111 Disease denotes infection MESH:D007239
165 10562-10570 Disease denotes COVID-19 MESH:C000657245
167 10625-10633 Disease denotes COVID-19 MESH:C000657245
174 11347-11355 Species denotes patients Tax:9606
175 10977-10990 Chemical denotes levetiracetam MESH:D000077287
176 10995-11004 Chemical denotes midazolam MESH:D008874
177 11040-11055 Chemical denotes benzodiazepines MESH:D001569
178 10747-10754 Disease denotes seizure MESH:D012640
179 10803-10811 Disease denotes COVID-19 MESH:C000657245
181 11459-11467 Disease denotes COVID-19 MESH:C000657245
183 11644-11651 Species denotes patient Tax:9606
189 12386-12394 Species denotes patients Tax:9606
190 12635-12643 Disease denotes epilepsy MESH:D004827
191 12767-12776 Disease denotes nystagmus MESH:D009759
192 12782-12788 Disease denotes ataxia MESH:D001259
193 12900-12909 Disease denotes inability MESH:D007319
195 12994-13002 Disease denotes COVID-19 MESH:C000657245
199 13021-13028 Species denotes patient Tax:9606
200 13114-13122 Species denotes patients Tax:9606
201 13361-13369 Species denotes patients Tax:9606
206 13758-13765 Species denotes patient Tax:9606
207 13901-13909 Species denotes patients Tax:9606
208 13613-13621 Disease denotes Epilepsy MESH:D004827
209 13892-13900 Disease denotes epilepsy MESH:D004827
216 14672-14680 Species denotes patients Tax:9606
217 14682-14688 Species denotes People Tax:9606
218 14197-14206 Disease denotes infection MESH:D007239
219 14285-14293 Disease denotes COVID-19 MESH:C000657245
220 14694-14702 Disease denotes epilepsy MESH:D004827
221 14710-14725 Disease denotes chronic disease MESH:D002908
224 15264-15272 Disease denotes Seizures MESH:D012640
225 15277-15285 Disease denotes COVID-19 MESH:C000657245
252 15436-15444 Species denotes patients Tax:9606
253 15651-15659 Species denotes children Tax:9606
254 15782-15788 Species denotes people Tax:9606
255 15894-15900 Species denotes people Tax:9606
256 16110-16116 Species denotes people Tax:9606
257 16214-16222 Species denotes patients Tax:9606
258 15319-15340 Disease denotes respiratory infection MESH:D012141
259 15363-15371 Disease denotes COVID-19 MESH:C000657245
260 15391-15415 Disease denotes neurological involvement MESH:D009422
261 15496-15511 Disease denotes CNS dysfunction MESH:D002493
262 15543-15551 Disease denotes seizures MESH:D012640
263 15614-15622 Disease denotes seizures MESH:D012640
264 15671-15679 Disease denotes seizures MESH:D012640
265 15684-15702 Disease denotes status epilepticus MESH:D013226
266 15704-15706 Disease denotes SE
267 15814-15822 Disease denotes epilepsy MESH:D004827
268 15859-15867 Disease denotes seizures MESH:D012640
269 15872-15874 Disease denotes SE
270 15905-15912 Disease denotes seizure MESH:D012640
271 16011-16023 Disease denotes hypocalcemia MESH:D006996
272 16098-16106 Disease denotes seizures MESH:D012640
273 16122-16130 Disease denotes COVID-19 MESH:C000657245
274 16205-16213 Disease denotes COVID-19 MESH:C000657245
275 16238-16246 Disease denotes seizures MESH:D012640
276 16343-16351 Disease denotes seizures MESH:D012640
277 16434-16442 Disease denotes epilepsy MESH:D004827
289 17009-17016 Species denotes patient Tax:9606
290 16512-16520 Disease denotes COVID-19 MESH:C000657245
291 16570-16586 Disease denotes systemic disease MESH:D034721
292 16597-16604 Disease denotes hypoxia MESH:D000860
293 16634-16653 Disease denotes multi-organ failure MESH:D009102
294 16694-16717 Disease denotes meningitis/encephalitis MESH:D004660
295 16793-16801 Disease denotes seizures MESH:D012640
296 16914-16933 Disease denotes Meningoencephalitis MESH:D008590
297 16950-16958 Disease denotes COVID 19 MESH:C000657245
298 16974-16982 Disease denotes seizures MESH:D012640
299 17112-17120 Disease denotes seizures MESH:D012640
328 17195-17203 Species denotes patients Tax:9606
329 17314-17321 Species denotes patient Tax:9606
330 17391-17399 Species denotes patients Tax:9606
331 17497-17504 Species denotes patient Tax:9606
332 17691-17699 Species denotes patients Tax:9606
333 17823-17831 Species denotes patients Tax:9606
334 17902-17910 Species denotes patients Tax:9606
335 18004-18012 Species denotes patients Tax:9606
336 18080-18088 Species denotes patients Tax:9606
337 17178-17186 Disease denotes seizures MESH:D012640
338 17209-17217 Disease denotes COVID-19 MESH:C000657245
339 17276-17278 Disease denotes SE
340 17338-17363 Disease denotes postencephalitic epilepsy MESH:D010301
341 17405-17413 Disease denotes COVID-19 MESH:C000657245
342 17430-17438 Disease denotes seizures MESH:D012640
343 17465-17473 Disease denotes seizures MESH:D012640
344 17510-17518 Disease denotes COVID-19 MESH:C000657245
345 17527-17546 Disease denotes meningoencephalitis MESH:D008590
346 17580-17588 Disease denotes seizures MESH:D012640
347 17675-17690 Disease denotes encephalopathic
348 17705-17713 Disease denotes COVID-19 MESH:C000657245
349 17758-17781 Disease denotes epileptiform discharges MESH:D019522
350 17792-17800 Disease denotes seizures MESH:D012640
351 17862-17870 Disease denotes epilepsy MESH:D004827
352 17922-17930 Disease denotes seizures MESH:D012640
353 18094-18102 Disease denotes COVID-19 MESH:C000657245
354 18121-18129 Disease denotes seizures MESH:D012640
355 18134-18136 Disease denotes SE
363 18558-18566 Species denotes patients Tax:9606
364 18257-18265 Disease denotes COVID-19 MESH:C000657245
365 18353-18361 Disease denotes COVID-19 MESH:C000657245
366 18492-18497 Disease denotes fever MESH:D005334
367 18572-18580 Disease denotes COVID-19 MESH:C000657245
368 18640-18648 Disease denotes epilepsy MESH:D004827
369 18772-18780 Disease denotes COVID-19 MESH:C000657245
371 18808-18816 Disease denotes Epilepsy MESH:D004827
373 19020-19028 Species denotes patients Tax:9606
378 19422-19432 Species denotes outpatient Tax:9606
379 19518-19526 Species denotes patients Tax:9606
380 19311-19319 Disease denotes epilepsy MESH:D004827
381 19724-19733 Disease denotes infection MESH:D007239
387 19911-19917 Species denotes people Tax:9606
388 19805-19813 Disease denotes epilepsy MESH:D004827
389 19935-19943 Disease denotes epilepsy MESH:D004827
390 19966-19974 Disease denotes epilepsy MESH:D004827
391 20018-20026 Disease denotes seizures MESH:D012640
409 20516-20524 Species denotes patients Tax:9606
410 20750-20758 Species denotes Patients Tax:9606
411 21004-21016 Species denotes participants Tax:9606
412 20259-20272 Chemical denotes levetiracetam MESH:D000077287
413 20404-20413 Chemical denotes midazolam MESH:D008874
414 20418-20426 Chemical denotes propofol MESH:D015742
415 20387-20394 Disease denotes seizure MESH:D012640
416 20501-20515 Disease denotes critically ill MESH:D016638
417 20553-20561 Disease denotes seizures MESH:D012640
418 20645-20653 Disease denotes COVID-19 MESH:C000657245
419 20657-20665 Disease denotes seizures MESH:D012640
420 20764-20772 Disease denotes Epilepsy MESH:D004827
421 20780-20788 Disease denotes COVID-19 MESH:C000657245
422 20842-20850 Disease denotes Epilepsy MESH:D004827
423 20873-20881 Disease denotes COVID-19 MESH:C000657245
424 20886-20894 Disease denotes Epilepsy MESH:D004827
425 21047-21055 Disease denotes COVID-19 MESH:C000657245
432 21472-21480 Species denotes patients Tax:9606
433 21573-21580 Species denotes patient Tax:9606
434 21302-21310 Disease denotes COVID-19 MESH:C000657245
435 21368-21374 Disease denotes stroke MESH:D020521
436 21419-21427 Disease denotes epilepsy MESH:D004827
437 21486-21505 Disease denotes refractory epilepsy MESH:D000069279
445 21823-21828 Species denotes child Tax:9606
446 22140-22148 Species denotes children Tax:9606
447 22290-22298 Species denotes patients Tax:9606
448 22382-22392 Species denotes outpatient Tax:9606
449 21785-21793 Disease denotes COVID-19 MESH:C000657245
450 21885-21893 Disease denotes epilepsy MESH:D004827
451 22154-22162 Disease denotes epilepsy MESH:D004827
454 23341-23349 Species denotes patients Tax:9606
455 23097-23105 Disease denotes epilepsy MESH:D004827
459 24379-24387 Species denotes patients Tax:9606
460 24340-24348 Disease denotes COVID-19 MESH:C000657245
461 24417-24425 Disease denotes COVID-19 MESH:C000657245
466 24780-24788 Disease denotes COVID-19 MESH:C000657245
467 24928-24935 Disease denotes seizure MESH:D012640
468 24984-24992 Disease denotes COVID-19 MESH:C000657245
469 24993-25002 Disease denotes infection MESH:D007239
473 27313-27317 Gene denotes Sage Gene:55511
474 27514-27518 Gene denotes Sage Gene:55511
475 27212-27226 Disease denotes advisory board
477 27690-27698 Disease denotes ORCID iD MESH:C535742

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 26-34 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T2 66-74 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T3 175-183 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T4 376-384 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T5 793-800 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T6 868-876 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T7 931-939 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T8 1634-1642 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T9 1721-1729 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T10 1779-1787 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T11 2013-2021 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T12 2129-2137 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T13 2250-2258 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T14 5269-5277 Phenotype denotes Seizures http://purl.obolibrary.org/obo/HP_0001250
T15 5378-5386 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T16 5468-5476 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T17 5489-5496 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T18 5652-5660 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T19 5680-5694 Phenotype denotes cardiac arrest http://purl.obolibrary.org/obo/HP_0001695
T20 5698-5704 Phenotype denotes stroke http://purl.obolibrary.org/obo/HP_0001297
T21 5798-5806 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T22 5860-5891 Phenotype denotes bilateral tonic–clonic seizures http://purl.obolibrary.org/obo/HP_0002069
T23 5922-5930 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T24 6151-6158 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T25 6251-6259 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T26 6373-6380 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T27 6459-6466 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T28 6533-6540 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T29 6746-6754 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T30 6882-6889 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T31 7008-7016 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T32 8075-8082 Phenotype denotes anxiety http://purl.obolibrary.org/obo/HP_0000739
T33 8088-8098 Phenotype denotes depression http://purl.obolibrary.org/obo/HP_0000716
T34 9386-9394 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T35 10747-10754 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T36 12635-12643 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T37 12767-12776 Phenotype denotes nystagmus http://purl.obolibrary.org/obo/HP_0000639
T38 12782-12788 Phenotype denotes ataxia http://purl.obolibrary.org/obo/HP_0001251
T39 13613-13621 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T40 13892-13900 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T41 14694-14702 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T42 15264-15272 Phenotype denotes Seizures http://purl.obolibrary.org/obo/HP_0001250
T43 15319-15340 Phenotype denotes respiratory infection http://purl.obolibrary.org/obo/HP_0011947
T44 15543-15551 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T45 15614-15622 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T46 15671-15679 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T47 15684-15702 Phenotype denotes status epilepticus http://purl.obolibrary.org/obo/HP_0002133
T48 15704-15706 Phenotype denotes SE http://purl.obolibrary.org/obo/HP_0002133
T49 15814-15822 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T50 15847-15867 Phenotype denotes symptomatic seizures http://purl.obolibrary.org/obo/HP_0011145
T51 15872-15874 Phenotype denotes SE http://purl.obolibrary.org/obo/HP_0002133
T52 15905-15912 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T53 16011-16023 Phenotype denotes hypocalcemia http://purl.obolibrary.org/obo/HP_0002901
T54 16086-16106 Phenotype denotes symptomatic seizures http://purl.obolibrary.org/obo/HP_0011145
T55 16238-16246 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T56 16343-16351 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T57 16434-16442 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T58 16597-16604 Phenotype denotes hypoxia http://purl.obolibrary.org/obo/HP_0012418
T59 16694-16704 Phenotype denotes meningitis http://purl.obolibrary.org/obo/HP_0001287
T60 16705-16717 Phenotype denotes encephalitis http://purl.obolibrary.org/obo/HP_0002383
T61 16793-16801 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T62 16974-16982 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T63 17112-17120 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T64 17178-17186 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T65 17276-17278 Phenotype denotes SE http://purl.obolibrary.org/obo/HP_0002133
T66 17355-17363 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T67 17430-17438 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T68 17465-17473 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T69 17568-17588 Phenotype denotes generalized seizures http://purl.obolibrary.org/obo/HP_0002197
T70 17786-17800 Phenotype denotes focal seizures http://purl.obolibrary.org/obo/HP_0007359
T71 17862-17870 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T72 17916-17930 Phenotype denotes focal seizures http://purl.obolibrary.org/obo/HP_0007359
T73 18121-18129 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T74 18134-18136 Phenotype denotes SE http://purl.obolibrary.org/obo/HP_0002133
T75 18492-18497 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T76 18640-18648 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T77 18808-18816 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T78 19311-19319 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T79 19805-19813 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T80 19935-19943 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T81 19966-19974 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T82 20018-20026 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T83 20387-20394 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T84 20553-20561 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T85 20657-20665 Phenotype denotes seizures http://purl.obolibrary.org/obo/HP_0001250
T86 20764-20772 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T87 20842-20850 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T88 20886-20894 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T89 21368-21374 Phenotype denotes stroke http://purl.obolibrary.org/obo/HP_0001297
T90 21419-21427 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T91 21497-21505 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T92 21885-21893 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T93 22154-22162 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T94 23097-23105 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T95 24928-24935 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T96 25473-25481 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T97 25513-25521 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T98 25669-25677 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T99 25709-25717 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250
T100 25874-25882 Phenotype denotes Epilepsy http://purl.obolibrary.org/obo/HP_0001250

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 1994-2002 http://purl.obolibrary.org/obo/GO_0007612 denotes Learning
T2 6587-6592 http://purl.obolibrary.org/obo/GO_0030431 denotes sleep
T3 6923-6928 http://purl.obolibrary.org/obo/GO_0030431 denotes sleep
T4 11799-11807 http://purl.obolibrary.org/obo/GO_0007612 denotes learning

0_colil

Id Subject Object Predicate Lexical cue
32942901-32275288-1063 15577-15578 32275288 denotes 3
32942901-32304092-1064 15888-15889 32304092 denotes 4
32942901-32275288-1065 16455-16456 32275288 denotes 3
32942901-32506549-1066 16764-16765 32506549 denotes 5
32942901-32416567-1067 16766-16767 32416567 denotes 6
32942901-32251791-1068 17017-17018 32251791 denotes 7
32942901-32344366-1069 17364-17365 32344366 denotes 8
32942901-32739397-1070 17493-17494 32739397 denotes 9
32942901-32251791-1071 17612-17613 32251791 denotes 7
32942901-32578124-1072 18162-18164 32578124 denotes 11
32942901-32327490-1073 18374-18376 32327490 denotes 13
32942901-32327490-1074 19760-19762 32327490 denotes 13
32942901-32588368-1075 20087-20089 32588368 denotes 15
32942901-20591171-1076 21380-21382 20591171 denotes 19
32942901-27998940-1077 21383-21385 27998940 denotes 20
32942901-32327490-1078 21594-21596 32327490 denotes 13
32942901-31801829-1080 21696-21698 31801829 denotes 24
32942901-31714640-1081 23052-23054 31714640 denotes 28
32942901-15857445-1079 21597-21599 15857445 denotes 21
32942901-25617692-1079 21597-21599 25617692 denotes 21
32942901-29127858-1079 21597-21599 29127858 denotes 21

TEST0

Id Subject Object Predicate Lexical cue
32942901-235-240-1063 15577-15578 ["32275288"] denotes 3
32942901-237-242-1064 15888-15889 ["32304092"] denotes 4
32942901-207-212-1065 16455-16456 ["32275288"] denotes 3
32942901-238-243-1066 16764-16765 ["32506549"] denotes 5
32942901-235-240-1067 16766-16767 ["32416567"] denotes 6
32942901-236-241-1068 17017-17018 ["32251791"] denotes 7
32942901-236-241-1069 17364-17365 ["32344366"] denotes 8
32942901-238-243-1070 17493-17494 ["32739397"] denotes 9
32942901-119-124-1071 17612-17613 ["32251791"] denotes 7
32942901-88-94-1072 18162-18164 ["32578124"] denotes 11
32942901-206-212-1073 18374-18376 ["32327490"] denotes 13
32942901-202-208-1074 19760-19762 ["32327490"] denotes 13
32942901-207-213-1075 20087-20089 ["32588368"] denotes 15
32942901-151-157-1076 21380-21382 ["20591171"] denotes 19
32942901-154-160-1077 21383-21385 ["27998940"] denotes 20
32942901-229-235-1078 21594-21596 ["32327490"] denotes 13
32942901-232-238-1079 21597-21599 ["29127858", "25617692", "15857445"] denotes 21
32942901-102-108-1080 21696-21698 ["31801829"] denotes 24
32942901-101-107-1081 23052-23054 ["31714640"] denotes 28

2_test

Id Subject Object Predicate Lexical cue
32942901-32275288-28639235 15577-15578 32275288 denotes 3
32942901-32304092-28639236 15888-15889 32304092 denotes 4
32942901-32275288-28639237 16455-16456 32275288 denotes 3
32942901-32506549-28639238 16764-16765 32506549 denotes 5
32942901-32416567-28639239 16766-16767 32416567 denotes 6
32942901-32251791-28639240 17017-17018 32251791 denotes 7
32942901-32344366-28639241 17364-17365 32344366 denotes 8
32942901-32739397-28639242 17493-17494 32739397 denotes 9
32942901-32251791-28639243 17612-17613 32251791 denotes 7
32942901-32578124-28639244 18162-18164 32578124 denotes 11
32942901-32327490-28639245 18374-18376 32327490 denotes 13
32942901-32327490-28639246 19760-19762 32327490 denotes 13
32942901-32588368-28639247 20087-20089 32588368 denotes 15
32942901-20591171-28639248 21380-21382 20591171 denotes 19
32942901-27998940-28639249 21383-21385 27998940 denotes 20
32942901-32327490-28639250 21594-21596 32327490 denotes 13
32942901-29127858-28639251 21597-21599 29127858 denotes 21
32942901-25617692-28639251 21597-21599 25617692 denotes 21
32942901-15857445-28639251 21597-21599 15857445 denotes 21
32942901-31801829-28639252 21696-21698 31801829 denotes 24
32942901-31714640-28639253 23052-23054 31714640 denotes 28

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-40 Sentence denotes The Impact of COVID-19 on Epilepsy Care:
T2 41-93 Sentence denotes A Survey of the American Epilepsy Society Membership
T3 95-103 Sentence denotes Abstract
T4 104-300 Sentence denotes The COVID-19 pandemic has impacted the delivery of care to people with epilepsy (PWE) in multiple ways including limitations on in-person contact and restrictions on neurophysiological procedures.
T5 301-442 Sentence denotes To better study the effect of the pandemic on PWE, members of the American Epilepsy Society were surveyed between April 30 and June 14, 2020.
T6 443-675 Sentence denotes There were 366 initial responses (9% response rate) and 337 respondents remained for analysis after screening out noncompleters and those not directly involved with clinical care; the majority were physicians from the United States.
T7 676-811 Sentence denotes About a third (30%) of respondents stated that they had patients with COVID-19 and reported no significant change in seizure frequency.
T8 812-940 Sentence denotes Conversely, one-third of respondents reported new onset seizures in patients with COVID-19 who had no prior history of seizures.
T9 941-1111 Sentence denotes The majority of respondents felt that there were at least some barriers for PWE in receiving appropriate clinical care, neurophysiologic procedures, and elective surgery.
T10 1112-1235 Sentence denotes Medication shortages were noted by approximately 30% of respondents, with no clear pattern in types of medication involved.
T11 1236-1286 Sentence denotes Telehealth was overwhelmingly found to have value.
T12 1287-1408 Sentence denotes Among the limitation of the survey was that it was administered at a single point in time in a rapidly changing pandemic.
T13 1409-1506 Sentence denotes The survey showed that almost all respondents were affected by the pandemic in a variety of ways.
T14 1508-1649 Sentence denotes The corona virus infectious disease-2019 (COVID-19) pandemic has had an exceptional impact on delivery of care to people with epilepsy (PWE).
T15 1650-1745 Sentence denotes In addition to obviously impacting PWE, the pandemic has also affected epilepsy care providers.
T16 1746-1955 Sentence denotes In mid-April, 2020, the American Epilepsy Society (AES) determined that a membership survey should be conducted to better understand the effects of the COVID-19 pandemic on members and the patients they serve.
T17 1956-2172 Sentence denotes The Quantitative Practical Use-Driven Learning Survey in Epilepsy (Q-PULSE) Taskforce was charged with creating a survey that would assess how the most important aspects of epilepsy care delivery were being affected.
T18 2173-2375 Sentence denotes Unlike typical Q-PULSE surveys that are sent only to National Association of Epilepsy Center directors, this survey was sent to all AES members, as it was intended to reflect broad practice experiences.
T19 2376-2481 Sentence denotes The survey was sent in late April 2020, and several emails were sent to encourage members to complete it.
T20 2482-2686 Sentence denotes The survey was open April 30 to June 14, 2020 The survey was publicized by AES to members through 3 e-blasts, several AES Connections e-newsletter items, AES Connect forum, and various social media posts.
T21 2687-2843 Sentence denotes The survey did not specifically screen for AES membership, and electronic publicity distribution meant that non-AES members may have been among respondents.
T22 2844-2948 Sentence denotes The initial survey questions did screen out respondents who were not directly involved in clinical care.
T23 2949-3108 Sentence denotes Of the 4193 average distribution for the 3 e-blasts, an average of 1448 (34%) opened each message, and a total of 434 recipients clicked through to the survey.
T24 3109-3228 Sentence denotes Overall, a total of 366 members responded to the survey (response rate of 9% of the total member e-blast distribution).
T25 3229-3384 Sentence denotes Of the 366 total initial respondents, 29 did not complete the survey (21 not directly involved in patient care and 8 completed only demographic questions).
T26 3385-3469 Sentence denotes A total of 337 respondents completed some portion of the remaining survey questions.
T27 3470-3551 Sentence denotes Because responses were not required, not all respondents completed all questions.
T28 3552-3641 Sentence denotes The AES Guidelines and Assessment Committee (GAC) was charged with analyzing the results.
T29 3642-3763 Sentence denotes A volunteer group of members of the GAC and a few members of the Q-PULSE Work Group summarized the results of the survey.
T30 3764-3877 Sentence denotes The results are divided into 4 parts: demographics, patient care issues, practice-related issues, and telehealth.
T31 3878-4003 Sentence denotes Because of its importance in the current pandemic, telehealth questions were separated from other practice-related questions.
T32 4004-4094 Sentence denotes Several questions were open ended, and the information from the survey is summarized here.
T33 4095-4158 Sentence denotes A PDF of the survey questions is provided in Online Appendix 1.
T34 4159-4276 Sentence denotes It is important to appreciate that the results presented are a snapshot of member practice and not clinical guidance.
T35 4278-4290 Sentence denotes Demographics
T36 4291-4332 Sentence denotes There were 337 respondents to the survey.
T37 4333-4383 Sentence denotes The majority of respondents (79%) were physicians.
T38 4384-4534 Sentence denotes Medical trainees constituted 7% of the respondents, while 5% were advanced practice providers, and 3% were electroencephalography (EEG) technologists.
T39 4535-4613 Sentence denotes Most respondents were from the United States (80%), while 7% were from Europe.
T40 4614-4695 Sentence denotes The rest, about 4% each, were from South America, Asia, and non-US North America.
T41 4696-4875 Sentence denotes Respondents were asked how they would describe the degree of community spread of COVID-19 cases in their region using subjective terms (no reported cases, mild, moderate, severe).
T42 4876-5121 Sentence denotes At the time the survey was conducted, one-half (50%) described their geographic region (American state or country) as “moderately” affected by the COVID-19 pandemic, while a quarter each described their region as “severely” or “mildly” affected.
T43 5122-5199 Sentence denotes Only one respondent was not aware of COVID-19 cases in their area (Figure 1).
T44 5200-5209 Sentence denotes Figure 1.
T45 5211-5243 Sentence denotes Concentration of COVID-19 cases.
T46 5245-5267 Sentence denotes Impact on Patient Care
T47 5269-5290 Sentence denotes Seizures and COVID-19
T48 5291-5408 Sentence denotes About a third (30%) of the survey respondents reported a suspected cause for new onset seizures in COVID-19 patients.
T49 5409-5537 Sentence denotes Most often the mechanism thought to be responsible for the seizures was lowered seizure threshold with preexisting risk factors.
T50 5538-5643 Sentence denotes Some respondents suspected viral invasion of the central nervous system (CNS) and injury from SARS-CoV-2.
T51 5644-5738 Sentence denotes Rarely, seizures were attributed to cardiac arrest or stroke that occurred during the illness.
T52 5739-5892 Sentence denotes Most survey respondents (63%) indicated that the new-onset seizures were mostly focal-onset with or without evolution to bilateral tonic–clonic seizures.
T53 5893-6000 Sentence denotes Other respondents identified seizures as generalized, electrographic only or unclassifiable almost equally.
T54 6001-6109 Sentence denotes One-third of respondents reported that they had PWE in their practice that had been diagnosed with COVID-19.
T55 6110-6169 Sentence denotes A majority of these PWE had no change in seizure frequency.
T56 6170-6281 Sentence denotes About 17% of the respondents noted worsening, while none noted an improvement in seizures in PWE with COVID-19.
T57 6282-6409 Sentence denotes In PWE who had not been infected with SARS-CoV-2, most respondents did not see a change in seizure frequency in their patients.
T58 6410-6519 Sentence denotes However, 10% of respondents noted a worsening in seizure frequency, while 5% noted an improvement (Figure 2).
T59 6520-6655 Sentence denotes Worsening of seizure frequency was attributed to increased stress, sleep deprivation, and reduced access to pharmacies and medications.
T60 6656-6860 Sentence denotes However, when survey participants were specifically asked if PWE were reporting increased seizures as a result of emotional stress, more than 80% of respondents either disagreed or were neutral or unsure.
T61 6861-6954 Sentence denotes Conversely, improved seizure control was attributed to better sleep and medication adherence.
T62 6955-6964 Sentence denotes Figure 2.
T63 6966-7006 Sentence denotes Effects of the COVID-19 pandemic on PWE.
T64 7008-7030 Sentence denotes Epilepsy Clinical Care
T65 7031-7128 Sentence denotes Concerns have been raised about the quality of care provided to PWE during the COVID-19 pandemic.
T66 7129-7296 Sentence denotes Forty-three percent of the survey respondents thought that PWE received the expected standard of care during the pandemic, while 34% thought that care was compromised.
T67 7297-7345 Sentence denotes The remaining 17% were either neutral or unsure.
T68 7346-7534 Sentence denotes The majority of respondents felt that there were at least some barriers for PWE in getting appropriate clinical care, testing (including EEG and video EEG monitoring) and elective surgery.
T69 7535-7822 Sentence denotes The reasons for these barriers were thought to include loss of employment and financial stress, lack of access to health care service due to closure, transportation issues, lack of access to technology for telehealth, and reluctance to seek care due to fear of viral outbreak (Figure 3).
T70 7823-8119 Sentence denotes Other barriers identified by some respondents were reduced access to specialty pharmacy services for patients with severe epilepsies, loss of insurance leading to lack of medication coverage, loss of behavioral health services, and increase in stress, anxiety, and depression due to the pandemic.
T71 8120-8332 Sentence denotes Respondents noted that overall, the COVID-19 pandemic has not resulted in a significant change in phone calls from patients to clinics, although both increased and decreased calls were reported in some instances.
T72 8333-8342 Sentence denotes Figure 3.
T73 8344-8393 Sentence denotes Barriers to care of PWE during COVID-19 pandemic.
T74 8395-8422 Sentence denotes Impact on Clinical Practice
T75 8424-8450 Sentence denotes Barriers to Providing Care
T76 8451-8523 Sentence denotes A range of barriers were reported in providing care during the pandemic.
T77 8524-8664 Sentence denotes Most frequently noted were limited access to in-person visits and nonemergency testing reported by 74% and 66% of respondents, respectively.
T78 8665-8883 Sentence denotes Provider fear related to the outbreak and concern for their own well-being was reported by nearly 30%, while lack of personal protective equipment (PPE) and financial considerations were reported by 25% of respondents.
T79 8884-8967 Sentence denotes Technological problems for telehealth visits were noted in only 15% of respondents.
T80 8968-9061 Sentence denotes Only 7% of respondents experienced no barriers in providing patient care during the pandemic.
T81 9062-9232 Sentence denotes One respondent noted that between the pandemic and Centers for Medicare and Medicaid Services (CMS) cutbacks on EEG reimbursement, continuing practice appeared difficult.
T82 9233-9608 Sentence denotes Respondents also cited the following additional practice-related barriers to providing care: prioritization of COVID over nonurgent care; suspensions of epilepsy monitoring units (EMUs), vagus nerve stimulator implantations, and presurgical evaluation and surgery; reopening logistics; staff cuts; and clinic staffing (eg, childcare challenges and fear of exposure to COVID).
T83 9609-9806 Sentence denotes Regarding when respondents expected to return services to pre-COVID-19 levels, the answers formed a normally distributed Bell-shaped curve between now and never, centered at approximately 6 months.
T84 9807-9844 Sentence denotes Only 9% of respondents were not sure.
T85 9845-9918 Sentence denotes Approximately 5% did not feel their practice would ever return to normal.
T86 9920-9948 Sentence denotes Neurophysiologic Evaluations
T87 9949-10112 Sentence denotes About half of respondents (47%) reported that EEGs were discouraged for patients admitted to the hospital with COVID-19 or those suspected of having the infection.
T88 10113-10224 Sentence denotes Even without restrictions, nearly a quarter (22%) reported they were doing fewer studies than usual (Figure 4).
T89 10225-10302 Sentence denotes About 9% responded they were no longer doing continuous video-EEG monitoring.
T90 10303-10379 Sentence denotes In the write in comments, many respondents noted that their EMUs had closed.
T91 10380-10580 Sentence denotes Very few respondents (2%) reported that they were doing more EEGs than usual; of this group, 5 were from institutions where there were no restrictions for performing EEGs during the COVID-19 pandemic.
T92 10581-10590 Sentence denotes Figure 4.
T93 10592-10643 Sentence denotes Inpatient EEG utilization during COVID-19 pandemic.
T94 10645-10681 Sentence denotes Medication Interactions or Shortages
T95 10682-10812 Sentence denotes Almost no respondents had seen unusual interactions between anti-seizure medications (ASM) and medications used to treat COVID-19.
T96 10813-10893 Sentence denotes Medications shortages were noted by approximately 44% of respondents (Figure 5).
T97 10894-11087 Sentence denotes In write-in comments, the most frequently noted shortages were of extended release levetiracetam and midazolam, and other shortages of several IV benzodiazepines were noted by some respondents.
T98 11088-11167 Sentence denotes However, it appears some of these shortages existed from prior to the pandemic.
T99 11168-11297 Sentence denotes By and large, there appeared to be no consistent pattern of shortages of conventional ASMs directly attributable to the pandemic.
T100 11298-11419 Sentence denotes The majority of shortage reports originated from patients; IV anesthetic shortages were reported by inpatient pharmacies.
T101 11420-11429 Sentence denotes Figure 5.
T102 11431-11477 Sentence denotes Medication shortages during COVID-19 pandemic.
T103 11479-11497 Sentence denotes Impact on Trainees
T104 11498-11624 Sentence denotes Trainees (residents and fellows) responded in low numbers and noted that the pandemic has harmed their educational experience.
T105 11625-11704 Sentence denotes They cited reduced patient volumes and canceled clinics as responsible factors.
T106 11705-11918 Sentence denotes Furthermore, the cancelling of interprofessional conferences and educational meetings limited learning and networking opportunities outside the home institution as well as the opportunity to present academic work.
T107 11920-11930 Sentence denotes Telehealth
T108 11931-12105 Sentence denotes Nearly all respondents (90%) indicated a willingness to use telehealth in some capacity; only 2% said that they had not used telehealth and did not plan to use it (Figure 6).
T109 12106-12195 Sentence denotes Many respondents had experienced benefits of telehealth over in-person clinic encounters.
T110 12196-12513 Sentence denotes The benefits included improved access, decreased no-show rates, observations of the home environment, participation of families/caregivers, general efficiency of the visits, flexibility for patients and providers, enhanced integration with multidisciplinary teams, and increased access to psychosocial care providers.
T111 12514-12801 Sentence denotes Respondents also reported that their recent telemedicine experience demonstrates that much of pertinent examinations for epilepsy care, especially for follow-up visits, can be done with telehealth (eg, mental status, gait, coordination, cranial nerves, nystagmus, and ataxia evaluation).
T112 12802-12964 Sentence denotes Problems identified by respondents included technical difficulties, lack of physical contact, and inability to perform diagnostic monitoring and laboratory tests.
T113 12965-12974 Sentence denotes Figure 6.
T114 12976-13012 Sentence denotes Telehealth during COVID-19 pandemic.
T115 13013-13099 Sentence denotes Certain patient populations emerged as likely to particularly benefit from telehealth.
T116 13100-13308 Sentence denotes This included patients living far away from clinics, needing to take extended time off from work to attend clinic visits, with disabilities and requiring transportation, or living in extended care facilities.
T117 13309-13582 Sentence denotes This survey also suggested that the most vulnerable patients are negatively affected by the use of telehealth services, in that the lack of internet access and/or video-capable device has resulted in suboptimal interaction or necessitated an in-person visits to the clinic.
T118 13583-13910 Sentence denotes The Veterans Administration’s Epilepsy Centers of Excellence longstanding experience with telehealth was cited as a model for utilization of telemedicine for providing direct patient care, reading EEG studies remotely or reviewing them for quality assurance, and provider-to-provider consultation in treating epilepsy patients.
T119 13911-14010 Sentence denotes The survey respondents emphasized concerns regarding continued reimbursement for telehealth visits.
T120 14011-14132 Sentence denotes Many respondents wanted advocacy for continued reimbursement parity for telemedicine visits compared to in-person visits.
T121 14134-14144 Sentence denotes Discussion
T122 14145-14681 Sentence denotes On March 11, 2020, concerned by the severity of the infection and the significant level of spread, the World Health Organization classified COVID-19 as a pandemic.1 One week later, the US CMS released guidance recommending that elective surgeries and nonessential medical procedures be postponed to preserve PPE, reduce exposure among health care workers, and allow for the redeployment of medical personnel to provide care where gaps existed.2 This guidance resulted in an unprecedented change in health care delivery for all patients.
T123 14682-14890 Sentence denotes People with epilepsy have a chronic disease, often associated with other comorbidities and daily medication use, making them particularly vulnerable to changes in health care delivery induced by the pandemic.
T124 14891-15063 Sentence denotes Moreover, medical practitioners suddenly found themselves confronted with finding innovative methods of delivering medical care, while worrying about their personal health.
T125 15064-15149 Sentence denotes It was against this backdrop that the AES commissioned this survey of its membership.
T126 15150-15262 Sentence denotes Importantly, this survey was not sent to PWE, rather it focused on AES members perspectives during the pandemic.
T127 15264-15285 Sentence denotes Seizures and COVID-19
T128 15286-15512 Sentence denotes Initially thought to be mainly a respiratory infection, it is now clear that COVID-19 is associated with neurological involvement in more than 30% of patients, with approximately 25% having symptoms indicating CNS dysfunction.
T129 15513-15729 Sentence denotes Fortunately, the incidence of seizures appears to be low (0.5%).3 Although there are case reports of seizures at onset in both adults and children, new-onset seizures and status epilepticus (SE) are rarely described.
T130 15730-16024 Sentence denotes In a recent multicenter, retrospective study of 304 people with no known history of epilepsy in China, neither acute symptomatic seizures nor SE was observed.4 Two people had seizure-like symptoms during hospitalization that were thought to be related to acute stress reaction and hypocalcemia.
T131 16025-16131 Sentence denotes There was no evidence suggesting an additional risk of acute symptomatic seizures in people with COVID-19.
T132 16132-16247 Sentence denotes About a third (30%) of respondents in the current survey reported seeing COVID-19 patients with new-onset seizures.
T133 16248-16456 Sentence denotes This high rate, which is much higher than we might expect given the reported rate of new-onset seizures in the literature (0.5%), is likely reflective of the population surveyed, namely epilepsy specialists.3
T134 16457-16913 Sentence denotes A number of mechanisms of neuropathogenesis related to COVID-19 have been described, including manifestations of systemic disease including hypoxia, metabolic derangements, and multi-organ failure; direct invasion of the nervous system (meningitis/encephalitis); and a postinfection immune-mediated process.5,6 All of these may lead to seizures, but the specific contribution of each mechanism is unclear, and in some cases the cause may be multifactorial.
T135 16914-17121 Sentence denotes Meningoencephalitis associated with COVID 19 with transient seizures has been described in one patient.7 The responses in the AES survey reflected similar uncertainty of possible mechanisms causing seizures.
T136 17122-17236 Sentence denotes There are very few data regarding the type of new-onset seizures seen in patients with COVID-19 in the literature.
T137 17237-17967 Sentence denotes There is a single case report of focal SE as a presenting manifestation in a patient with underlying postencephalitic epilepsy.8 A small case series of 7 patients with COVID-19 presenting with seizures, of which 4 had new-onset seizures, has been reported.9 A patient with COVID-19 related meningoencephalitis was reported to have generalized seizures lasting about a minute.7 One EEG-based case series demonstrates abnormalities seen in encephalopathic patients with COVID-19, including generalized slowing, generalized epileptiform discharges and focal seizures, although many of the patients in the series had preexisting epilepsy.10 In this study, there were 2 patients with focal seizures, 1 was new onset and 1 was in a PWE.
T138 17968-18073 Sentence denotes Additionally, in this study several patients had generalized periodic discharges of triphasic morphology.
T139 18074-18167 Sentence denotes Other patients with COVID-19 related new onset seizures and SE have also been described.11,12
T140 18168-18266 Sentence denotes Respondents in the current survey did not notice an increase in susceptibility of PWE to COVID-19.
T141 18267-18498 Sentence denotes This is supported by a consensus statement which finds no increased risk of acquiring COVID-19 in most PWE.13 Exceptions include PWE who are being treated with immunosuppressant medications or those particularly sensitive to fever.
T142 18499-18781 Sentence denotes However, a recent study that reported on EEG findings in 8 patients with COVID-19 related neurologic problems found 5 (63%) had a history of epilepsy.10 These authors raised the concern that PWE may be at increased risk developing neurologic manifestations if they acquire COVID-19.
T143 18783-18821 Sentence denotes Obtaining and Delivering Epilepsy Care
T144 18822-18941 Sentence denotes Concerns were raised in this survey that PWE could not get the usual care for their medical issues during the pandemic.
T145 18942-19049 Sentence denotes Many of these issues were due to new financial and logistical constraints for patients during the pandemic.
T146 19050-19134 Sentence denotes No comparable data regarding these issues are currently available in the literature.
T147 19135-19230 Sentence denotes Care was also affected due to limitations imposed by hospitals, clinics, and medical practices.
T148 19231-19378 Sentence denotes Institutions across the United States began to restrict or cancel admissions to epilepsy monitoring units (which are typically elective in nature).
T149 19379-19762 Sentence denotes In addition, performing both inpatient and outpatient EEGs was significantly reduced due to the close contact of the EEG technologist with patients and to reduce depletion of PPE.14 Telemedicine visits were encouraged for the care of PWE during the pandemic wherever possible to reduce the risk for PWE and their family for being exposed to the infection in health care facilities.13
T150 19763-19879 Sentence denotes The effect of reduced access to in-person epilepsy care and neurodiagnostic procedures has not been clearly studied.
T151 19880-20089 Sentence denotes An Italian study that surveyed people with and without epilepsy found that those with epilepsy reported a significantly increased risk of seizures and difficulties in obtaining follow-up clinic appointments.15
T152 20090-20163 Sentence denotes Shortage of ASM has not been a major concern during the current pandemic.
T153 20164-20273 Sentence denotes Most respondents did not notice lack of availability of ASM, with the exception of long acting levetiracetam.
T154 20274-20562 Sentence denotes However, the Food and Drug Administration has reported intermittent shortages of medications used to treat acute seizure, such as midazolam and propofol, during the pandemic.16 This is likely due to use of these medications in critically ill patients, not necessarily those with seizures.
T155 20563-20674 Sentence denotes There is also little evidence of the effects of various medications used to treat COVID-19 on seizures and ASM.
T156 20675-20789 Sentence denotes In response, the AES Treatments Committee has created a resource, Managing Patients with Epilepsy during COVID-19:
T157 20790-21148 Sentence denotes Pharmacotherapy-related Recommendations.17 American Epilepsy Society has created a COVID-19 and Epilepsy web portal with information relating to various aspect to care delivery.18 Interestingly, despite almost all participants being impacted in some way by COVID-19, only 41% of respondents to the survey were aware of these resources, and 38% had used them.
T158 21149-21216 Sentence denotes A campaign to increase awareness of this resource may help members.
T159 21218-21228 Sentence denotes Telehealth
T160 21229-21698 Sentence denotes The value of telehealth in neurology has been recognized well before the COVID-19 pandemic, with particularly successful implementation in stroke care.19,20 The feasibility of telehealth in epilepsy care, including delivery of complex care to patients with refractory epilepsy, has similarly been demonstrated, with comparable outcome and high patient satisfaction.13,21-23 The lack of commensurate reimbursement has historically been the barrier to greater adoption.24
T161 21699-21803 Sentence denotes Several early studies have examined the effect of transition to telehealth during the COVID-19 pandemic.
T162 21804-22005 Sentence denotes A recent survey of child neurologists conducting telehealth encounters, in which epilepsy was somewhat overrepresented, revealed >90% satisfactory encounters despite 40% reporting technical challenges.
T163 22006-22511 Sentence denotes Most (86%) reported intending to pursue telehealth in future encounters.25 An international survey of pediatric neurologists treating children with epilepsy revealed that about 25% of practitioners were seeing outpatients exclusively with telehealth and 95% were seeing at least some patients by telehealth.26 A US-based single hospital system evaluation revealed that 67% of outpatient visits were completed via telehealth, 32% with phone visits, and only 1% of visits were in-person clinic encounters.27
T164 22512-22620 Sentence denotes Similar to previous studies, the respondents in the current survey overwhelmingly found value in telehealth.
T165 22621-22689 Sentence denotes Many benefits were noted, including efficiency of the clinic visits.
T166 22690-22853 Sentence denotes Respondents even noted that many of the examination elements that they routinely perform, such as mental status and gait evaluations, could be done via telehealth.
T167 22854-22950 Sentence denotes One shortcoming that was mentioned was the lack of diagnostic monitoring and laboratory testing.
T168 22951-23054 Sentence denotes However, a recent randomized trial revealed little benefit in monitoring serum levels of modern ASMs.28
T169 23055-23287 Sentence denotes Whereas previous efforts in telehealth in epilepsy care have focused on the delivery of care to resource-limited or poorly accessible regions, the current situation has affected health care delivery across all socioeconomic spectra.
T170 23288-23441 Sentence denotes Unfortunately, the most socioeconomically vulnerable patients have difficulty in getting telehealth services as well due to lack of access to technology.
T171 23442-23593 Sentence denotes This is an area that should be promptly and actively addressed, particularly since the near-term outlook for the pandemic remains extremely concerning.
T172 23594-23701 Sentence denotes An important consideration about telehealth raised by respondents to the survey is continued reimbursement.
T173 23702-23946 Sentence denotes While there was overwhelming recognition of the value of telehealth and many respondents saw the value in continuing it long term, they expressed concern that reimbursement models changed after the pandemic, they would be unable to continue it.
T174 23947-24124 Sentence denotes Encouragingly, professional societies are collaborating in a variety of way to advocate for telehealth for PWE as well as others that greatly benefit from this method of care.29
T175 24126-24137 Sentence denotes Limitations
T176 24138-24264 Sentence denotes There are several limitations inherent in this type of study including the potential for recall, sample, and responder biases.
T177 24265-24399 Sentence denotes Furthermore, the survey asks clinicians their impressions of the impact of COVID-19 on PWE in their practice, not patients themselves.
T178 24400-24542 Sentence denotes In addition, the COVID-19 pandemic has been a rapidly evolving phenomenon and this survey represents a snapshot in time early in the pandemic.
T179 24543-24634 Sentence denotes Responses might change if members were surveyed later in the pandemic or even postpandemic.
T180 24636-24647 Sentence denotes Conclusions
T181 24648-24798 Sentence denotes This survey of AES membership conducted in May and June 2020 found that almost all respondents had been impacted in some way by the COVID-19 pandemic.
T182 24799-24842 Sentence denotes Key “Takeaways” are summarized in Figure 7.
T183 24843-25003 Sentence denotes Most health care providers did not perceive that PWE have experienced an increase in seizure frequency during the pandemic or as a result of COVID-19 infection.
T184 25004-25177 Sentence denotes There are many barriers to care that have occurred; however, the pandemic has also forced innovations, such as in telehealth, that have led to enhancements in care delivery.
T185 25178-25334 Sentence denotes The survey identified areas in which to continue to provide services to AES members so that they may more effectively deliver the best possible care to PWE.
T186 25335-25344 Sentence denotes Figure 7.
T187 25346-25360 Sentence denotes Key takeaways.
T188 25362-25383 Sentence denotes Supplemental Material
T189 25384-25487 Sentence denotes Supplemental Material, Appendix_1-AES_COVID_Survey_Questions - The Impact of COVID-19 on Epilepsy Care:
T190 25488-25540 Sentence denotes A Survey of the American Epilepsy Society Membership
T191 25541-25577 Sentence denotes Click here for additional data file.
T192 25578-25683 Sentence denotes Supplemental Material, Appendix_1-AES_COVID_Survey_Questions for The Impact of COVID-19 on Epilepsy Care:
T193 25684-25747 Sentence denotes A Survey of the American Epilepsy Society Membership by Dara V.
T194 25748-25750 Sentence denotes F.
T195 25751-25767 Sentence denotes Albert, Rohit R.
T196 25768-25782 Sentence denotes Das, Jayant N.
T197 25783-25813 Sentence denotes Acharya, Jong Woo Lee, John R.
T198 25814-25843 Sentence denotes Pollard, Vineet Punia, Joy A.
T199 25844-25863 Sentence denotes Keller and Aatif M.
T200 25864-25891 Sentence denotes Husain in Epilepsy Currents
T201 25893-25908 Sentence denotes Acknowledgments
T202 25909-26023 Sentence denotes The authors would like to acknowledge the members of the AES Q-PULSE Task Force who created the survey instrument:
T203 26024-26074 Sentence denotes Nicholas Beimer, MD; Mesha-Gay Brown, MD; Brian T.
T204 26075-26100 Sentence denotes Cabaniss, MD; Cristina Y.
T205 26101-26160 Sentence denotes Go, MD; Kyung-Wha Kim, MD; Katherine Noe, MD, PhD; Imran H.
T206 26161-26213 Sentence denotes Quraishi, MD, PhD; Tung Tran, MD; Daniel Winkel, MD.
T207 26214-26381 Sentence denotes The authors would also like to acknowledge the members of the AES Guidelines and Assessments Committee and Council on Clinical Activities who reviewed this manuscript:
T208 26382-26461 Sentence denotes Naoki Akamatsu, MD, PhD; Christine Baca, MD; Michael Gelfand, MD, PhD; Emily L.
T209 26462-26482 Sentence denotes Johnson, MD; Lisa V.
T210 26483-26518 Sentence denotes Knopf, MD; Appaji Rayi, MD; John M.
T211 26519-26622 Sentence denotes Stern, MD, MA; Elissa Yozawitz, MD; Barry Gidal, PharmD; Anup Patel MD, MBA; and Timothy Welty, PharmD.
T212 26623-26755 Sentence denotes Finally, the authors would like to acknowledge Penny Dacks, PhD, AES Associate Executive Director, for her support for this project.
T213 26756-26793 Sentence denotes Declaration of Conflicting Interests:
T214 26794-26940 Sentence denotes The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
T215 26941-26947 Sentence denotes J.N.A:
T216 26948-26978 Sentence denotes Consultant for SK Lifescience.
T217 26979-26985 Sentence denotes J.W.L:
T218 26986-27091 Sentence denotes Cash compensation from Digitrace and Teladoc; grant from Enagage Therapeutics; co-founder of Soterya Inc.
T219 27092-27098 Sentence denotes J.R.P:
T220 27099-27145 Sentence denotes Stock ownership in Cognizance biomarkers, LLC.
T221 27146-27152 Sentence denotes A.M.H:
T222 27153-27570 Sentence denotes Editor for Journal of Clinical Neurophysiology; scientific advisory board or consultant for Marinus Pharmaceuticals, UCB Pharmaceuticals, Jazz Pharmaceuticals, Sage Therapeutics, Eisai Pharmaceuticals, and Neurelis Pharmaceuticals; royalties from Springer Publishers, Demos Medical Publishing, and Wolters Kluwer; research support from Marinus Pharmaceuticals, Sage Therapeutics, Biogen Idec, and UCB Pharmaceuticals.
T223 27571-27579 Sentence denotes Funding:
T224 27580-27689 Sentence denotes The author(s) received no financial support for the research, authorship, and/or publication of this article.
T225 27690-27699 Sentence denotes ORCID iD:
T226 27700-27706 Sentence denotes Joy A.
T227 27707-27752 Sentence denotes Keller https://orcid.org/0000-0002-1483-6859
T228 27753-27761 Sentence denotes Aatif M.
T229 27762-27807 Sentence denotes Husain https://orcid.org/0000-0001-7954-1755
T230 27808-27830 Sentence denotes Supplemental Material:
T231 27831-27890 Sentence denotes Supplemental material for this article is available online.

MyTest

Id Subject Object Predicate Lexical cue
32942901-32275288-28639235 15577-15579 32275288 denotes 3
32942901-32304092-28639236 15888-15890 32304092 denotes 4
32942901-32275288-28639237 16455-16457 32275288 denotes 3
32942901-32506549-28639238 16764-16765 32506549 denotes 5
32942901-32416567-28639239 16766-16768 32416567 denotes 6
32942901-32251791-28639240 17017-17019 32251791 denotes 7
32942901-32344366-28639241 17364-17366 32344366 denotes 8
32942901-32739397-28639242 17493-17495 32739397 denotes 9
32942901-32251791-28639243 17612-17614 32251791 denotes 7
32942901-32578124-28639244 18162-18164 32578124 denotes 11
32942901-32327490-28639245 18374-18377 32327490 denotes 13
32942901-32327490-28639246 19760-19763 32327490 denotes 13
32942901-32588368-28639247 20087-20090 32588368 denotes 15
32942901-20591171-28639248 21380-21382 20591171 denotes 19
32942901-27998940-28639249 21383-21386 27998940 denotes 20
32942901-32327490-28639250 21594-21596 32327490 denotes 13
32942901-29127858-28639251 21597-21599 29127858 denotes 21
32942901-25617692-28639251 21597-21599 25617692 denotes 21
32942901-15857445-28639251 21597-21599 15857445 denotes 21
32942901-31801829-28639252 21696-21699 31801829 denotes 24
32942901-31714640-28639253 23052-23055 31714640 denotes 28